265 related articles for article (PubMed ID: 9608876)
1. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
[TBL] [Abstract][Full Text] [Related]
2. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
[TBL] [Abstract][Full Text] [Related]
3. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats.
Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K
Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205
[TBL] [Abstract][Full Text] [Related]
5. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
[TBL] [Abstract][Full Text] [Related]
6. [A TRH analog (DN-1417). Effects on the levels of monoamines and the metabolites in the various brain regions in rats].
Nagai Y; Narumi S; Miyamoto M; Shima T; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):209-20. PubMed ID: 3924795
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute administration of hypericum perforatum-CO2 extract on dopamine and serotonin release in the rat central nervous system.
Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
Pharmacopsychiatry; 2000 Jan; 33(1):14-8. PubMed ID: 10721879
[TBL] [Abstract][Full Text] [Related]
8. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
9. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
10. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
[TBL] [Abstract][Full Text] [Related]
11. [Interactions of cerebral serotonin and catecholamines].
Watanabe Y
Nihon Yakurigaku Zasshi; 1983 May; 81(5):365-83. PubMed ID: 6195056
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
[TBL] [Abstract][Full Text] [Related]
13. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
14. Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.
Yoshitake T; Kehr J; Yoshitake S; Fujino K; Nohta H; Yamaguchi M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):177-83. PubMed ID: 15203027
[TBL] [Abstract][Full Text] [Related]
15. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
16. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
[TBL] [Abstract][Full Text] [Related]
17. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinami de, as studied by intracerebral microdialysis.
Itoh Y; Ogasawara T; Yamazaki A; Ukai Y; Miura A; Kimura K
J Pharmacol Exp Ther; 1994 Jan; 268(1):255-61. PubMed ID: 8301565
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
Lan KC; Ma T; Lin-Shiau SY; Liu SH; Ho IK
J Biomed Sci; 2008 May; 15(3):391-403. PubMed ID: 17934798
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
Yamamura M; Suzuki M; Matsumoto K
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]